Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71

Hand, foot and mouth disease (HFMD) is a childhood disease caused by enterovirus A71 (EV-A71) and coxsackievirus A16 (CV-A16). Capsid loops are important epitopes for EV-A71 and CV-A16. Seven chimeric EV-A71 (ChiE71) involving VP1 BC (45.5% similarity), DE, EF, GH and HI loops, VP2 EF loop and VP3 G...

Full description

Bibliographic Details
Main Authors: Xiu Hui Tan, Wei Lim Chong, Vannajan Sanghiran Lee, Syahril Abdullah, Kartini Jasni, Saiful Qushairi Suarni, David Perera, I-Ching Sam, Yoke Fun Chan
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/11/8/1363
_version_ 1827728557616398336
author Xiu Hui Tan
Wei Lim Chong
Vannajan Sanghiran Lee
Syahril Abdullah
Kartini Jasni
Saiful Qushairi Suarni
David Perera
I-Ching Sam
Yoke Fun Chan
author_facet Xiu Hui Tan
Wei Lim Chong
Vannajan Sanghiran Lee
Syahril Abdullah
Kartini Jasni
Saiful Qushairi Suarni
David Perera
I-Ching Sam
Yoke Fun Chan
author_sort Xiu Hui Tan
collection DOAJ
description Hand, foot and mouth disease (HFMD) is a childhood disease caused by enterovirus A71 (EV-A71) and coxsackievirus A16 (CV-A16). Capsid loops are important epitopes for EV-A71 and CV-A16. Seven chimeric EV-A71 (ChiE71) involving VP1 BC (45.5% similarity), DE, EF, GH and HI loops, VP2 EF loop and VP3 GH loop (91.3% similarity) were substituted with corresponding CV-A16 loops. Only ChiE71-1-BC, ChiE71-1-EF, ChiE71-1-GH and ChiE71-3-GH were viable. EV-A71 and CV-A16 antiserum neutralized ChiE71-1-BC and ChiE71-1-EF. Mice immunized with inactivated ChiE71 elicited high IgG, IFN-γ, IL-2, IL-4 and IL-10. Neonatal mice receiving passive transfer of WT EV-A71, ChiE71-1-EF and ChiE71-1-BC immune sera had 100%, 80.0% and no survival, respectively, against lethal challenges with EV-A71, suggesting that the substituted CV-A16 loops disrupted EV-A71 immunogenicity. Passive transfer of CV-A16, ChiE71-1-EF and ChiE71-1-BC immune sera provided 40.0%, 20.0% and 42.9% survival, respectively, against CV-A16. One-day-old neonatal mice immunized with WT EV-A71, ChiE71-1-BC, ChiE71-1-EF and CV-A16 achieved 62.5%, 60.0%, 57.1%, and no survival, respectively, after the EV-A71 challenge. Active immunization using CV-A16 provided full protection while WT EV-A71, ChiE71-1-BC and ChiE71-1-EF immunization showed partial cross-protection in CV-A16 lethal challenge with survival rates of 50.0%, 20.0% and 40%, respectively. Disruption of a capsid loop could affect virus immunogenicity, and future vaccine design should include conservation of the enterovirus capsid loops.
first_indexed 2024-03-10T23:31:43Z
format Article
id doaj.art-8510d684c40e45e396dbba2fc4c754d1
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T23:31:43Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-8510d684c40e45e396dbba2fc4c754d12023-11-19T03:18:07ZengMDPI AGVaccines2076-393X2023-08-01118136310.3390/vaccines11081363Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71Xiu Hui Tan0Wei Lim Chong1Vannajan Sanghiran Lee2Syahril Abdullah3Kartini Jasni4Saiful Qushairi Suarni5David Perera6I-Ching Sam7Yoke Fun Chan8Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, MalaysiaDepartment of Chemistry, Center of Theoretical and Computational Physics, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, MalaysiaDepartment of Chemistry, Center of Theoretical and Computational Physics, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, MalaysiaDepartment of Biomedical Sciences, Faculty of Medicine & Health Sciences, Universiti Putra Malaysia, Serdang 43400, MalaysiaComparative Medicine and Technology Unit, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, MalaysiaComparative Medicine and Technology Unit, Institute of Bioscience, Universiti Putra Malaysia, Serdang 43400, MalaysiaInstitute of Health and Community Medicine, Universiti Malaysia Sarawak, Kota Samarahan 94300, MalaysiaDepartment of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, MalaysiaDepartment of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur 50603, MalaysiaHand, foot and mouth disease (HFMD) is a childhood disease caused by enterovirus A71 (EV-A71) and coxsackievirus A16 (CV-A16). Capsid loops are important epitopes for EV-A71 and CV-A16. Seven chimeric EV-A71 (ChiE71) involving VP1 BC (45.5% similarity), DE, EF, GH and HI loops, VP2 EF loop and VP3 GH loop (91.3% similarity) were substituted with corresponding CV-A16 loops. Only ChiE71-1-BC, ChiE71-1-EF, ChiE71-1-GH and ChiE71-3-GH were viable. EV-A71 and CV-A16 antiserum neutralized ChiE71-1-BC and ChiE71-1-EF. Mice immunized with inactivated ChiE71 elicited high IgG, IFN-γ, IL-2, IL-4 and IL-10. Neonatal mice receiving passive transfer of WT EV-A71, ChiE71-1-EF and ChiE71-1-BC immune sera had 100%, 80.0% and no survival, respectively, against lethal challenges with EV-A71, suggesting that the substituted CV-A16 loops disrupted EV-A71 immunogenicity. Passive transfer of CV-A16, ChiE71-1-EF and ChiE71-1-BC immune sera provided 40.0%, 20.0% and 42.9% survival, respectively, against CV-A16. One-day-old neonatal mice immunized with WT EV-A71, ChiE71-1-BC, ChiE71-1-EF and CV-A16 achieved 62.5%, 60.0%, 57.1%, and no survival, respectively, after the EV-A71 challenge. Active immunization using CV-A16 provided full protection while WT EV-A71, ChiE71-1-BC and ChiE71-1-EF immunization showed partial cross-protection in CV-A16 lethal challenge with survival rates of 50.0%, 20.0% and 40%, respectively. Disruption of a capsid loop could affect virus immunogenicity, and future vaccine design should include conservation of the enterovirus capsid loops.https://www.mdpi.com/2076-393X/11/8/1363enterovirus A71coxsackievirus A16enterovirushandfoot and mouth diseasecapsid loop
spellingShingle Xiu Hui Tan
Wei Lim Chong
Vannajan Sanghiran Lee
Syahril Abdullah
Kartini Jasni
Saiful Qushairi Suarni
David Perera
I-Ching Sam
Yoke Fun Chan
Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71
Vaccines
enterovirus A71
coxsackievirus A16
enterovirus
hand
foot and mouth disease
capsid loop
title Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71
title_full Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71
title_fullStr Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71
title_full_unstemmed Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71
title_short Substitution of Coxsackievirus A16 VP1 BC and EF Loop Altered the Protective Immune Responses in Chimera Enterovirus A71
title_sort substitution of coxsackievirus a16 vp1 bc and ef loop altered the protective immune responses in chimera enterovirus a71
topic enterovirus A71
coxsackievirus A16
enterovirus
hand
foot and mouth disease
capsid loop
url https://www.mdpi.com/2076-393X/11/8/1363
work_keys_str_mv AT xiuhuitan substitutionofcoxsackievirusa16vp1bcandefloopalteredtheprotectiveimmuneresponsesinchimeraenterovirusa71
AT weilimchong substitutionofcoxsackievirusa16vp1bcandefloopalteredtheprotectiveimmuneresponsesinchimeraenterovirusa71
AT vannajansanghiranlee substitutionofcoxsackievirusa16vp1bcandefloopalteredtheprotectiveimmuneresponsesinchimeraenterovirusa71
AT syahrilabdullah substitutionofcoxsackievirusa16vp1bcandefloopalteredtheprotectiveimmuneresponsesinchimeraenterovirusa71
AT kartinijasni substitutionofcoxsackievirusa16vp1bcandefloopalteredtheprotectiveimmuneresponsesinchimeraenterovirusa71
AT saifulqushairisuarni substitutionofcoxsackievirusa16vp1bcandefloopalteredtheprotectiveimmuneresponsesinchimeraenterovirusa71
AT davidperera substitutionofcoxsackievirusa16vp1bcandefloopalteredtheprotectiveimmuneresponsesinchimeraenterovirusa71
AT ichingsam substitutionofcoxsackievirusa16vp1bcandefloopalteredtheprotectiveimmuneresponsesinchimeraenterovirusa71
AT yokefunchan substitutionofcoxsackievirusa16vp1bcandefloopalteredtheprotectiveimmuneresponsesinchimeraenterovirusa71